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Abstract 
Understanding the regulation of pubertal timing has relevance to developmental and human biology, and 
to the pathogenesis of various diseases. Recent large-scale genome-wide association studies for puberty 
timing and adult height, body mass index (BMI) and central body shape provide evidence for shared 
biological mechanisms that regulate these traits. There is substantial genetic overlap between age at 
menarche in women and BMI, with almost invariable directional consistency with the epidemiological 
associations between earlier menarche and higher BMI. By contrast, the genetic loci identified for age at 
menarche are largely distinct from those identified for central body shape, while alleles that confer earlier 
menarche can be associated with taller or shorter adult height. The findings of population-based studies 
for age at menarche show increasing relevance for other studies of rare monogenic disorders and enrich 
our understanding of the mechanisms that regulate the timing of puberty and reproductive function.  
 
Introduction 
Puberty is the process of attainment of reproductive maturity and involves a range of physiological 
changes. The timings of specific pubertal milestones serve as markers of the tempo of development. Age 
at menarche, a woman’s first menstrual bleed, is reasonably well-recalled and is widely recorded in 
epidemiological studies. It has an estimated heritability of ~50% in contemporary western settings1 and 
is associated with later life risks for type 2 diabetes, cardiovascular disease and various other health 
outcomes 2, 3. The lack of similar well-recalled pubertal measures in men means that similar data are yet 
sparse. Earlier puberty timing is generally, but not invariably, associated with higher risks for adverse 
health outcomes, and therefore the global declines in average ages of puberty in females4–9 and males10 
have important relevance for health. These secular trends appear to be driven by increases in childhood 
BMI, which to some extent may underlie many of the later health risks10,11.  Recent genetic studies have 
shed light on the mechanisms linking weight status to puberty timing, and also other biological pathways 
that might independently link puberty timing to later health.  
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Rare genetic disorders of puberty 
Rare mutations in >20 genes that disrupt the gonadotropin-releasing hormone (GnRH) axis have been 
described12. Those that disrupt embryonic migration of GnRH producing cells from the nasal placode also 
cause anosmia (Kallman syndrome)13. Mutations in other genes that encode hypothalamic 
neurotransmitters or their receptors, rather than GnRH cell migration, typically cause normosmic 
hypogonadotropic hypogonadism; these include the genes for kisspeptin (KISS1), neurokinin B (TAC3)   
and GnRH (GNRH1) and their receptors (KISSR, TACR3 and GNRHR). Hypogonadotropic hypogonadism 
associated with other pituitary hormone deficiencies also results from mutations that disrupt pituitary 
development, such as in HESX1 and SOX2. 
Rare mutations in the genes that encode the pituitary hormones follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH) have differing effects in males and females. In females, absent puberty and 
ovarian failure are consequences of deleterious mutations in the FSH β-subunit14 or FSH receptor genes 
(FSHR)15. By contrast, affected males have reduced spermogenesis without other features of gonadal 
failure16. Only one consanguineous kindred is reported with a deleterious mutation in the LH gene17. The 
homozygous proband had bioinactive LH and absent puberty at age 17, while heterozygous males 
reported variable infertility but normal puberty, and heterozygous females had normal sexual 
development and were fertile. 
Few genetic disorders are described that result in precocious puberty. As a mirror image of the 
hypogonadotropic hypogonadism phenotype due to loss of function mutations in KISS  or KISSR, 
activating mutations in these genes result in precocious puberty, at least in girls18,19. A recent study of 40 
members of 15 families affected by precocious puberty used whole-exome sequencing to identify 
paternally-inherited mutations in MKRN320, an exclusively paternally-expressed gene located in the 
imprinted Prader–Willi syndrome region. Since that report of deleterious mutations in 15 affected 
members of 5 families from Brazil, USA and Europe20, MKRN3 mutations have also been described in 2/6 
affected families21 and in 8/215 apparently sporadic cases22. Studies in mice indicate that MKRN3 may act 
as a hypothalamic repressor of puberty onset20.  
Recently, various genetic disorders of puberty associated with ataxia have been described. Rare 
mutations in POLR3A that disrupt RNA polymerase cause hypomyelinating leukodystrophy23. The 
combination of ataxia and hypogonadism is also seen in disorders of ubiquitination due to rare mutations 
in RNF216 and OTUD424, and in individuals with Gordon Holmes syndrome as a result of mutations in 
CHIP (also called STUB1)25,26.    
Genetic disorders of both puberty and adiposity 
The adipocyte-derived hormone leptin and its receptor link nutritional status to the GnRH axis. Rare 
deleterious mutations in the leptin gene (LEP) cause severe early onset obesity with hyperphagia27. 
Furthermore, as in the mouse model28, affected individuals have hypogonadotropic hypogonadism29,30.  
Leptin therapy in children with leptin deficiency allows normal puberty timing rather than precocious 
puberty31, suggesting that leptin is necessary for GnRH axis activity, but is not itself the trigger for 
puberty timing32. Rare deleterious mutations in LEPR cause severe, early-onset obesity, and an 
apparently less severe reproductive phenotype of abnormally delayed rather than absent puberty, with 
irregular menses from age 20 years and normal adult estradiol, luteinizing hormone, and follicle-
stimulating hormone levels reported in the 3 affected women33. Converse to those disorders of delayed 
puberty and excess adiposity, rare mutations in POLD1 were recently reported to cause hypogonadism in 
males associated with lipodystrophy (particularly lack of subcutaneous adipose tissue) and deafness34. 
Affected individuals have low BMI and limb muscle mass, but are insulin resistant. POLD1 regulates DNA 
polymerase activity, but it is yet unclear how this relates to disruptions in gonadal function and adipose 
tissue development and metabolism. 
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Recent genome-wide association studies 
In contrast to the long history of reports of mutations in cases and families affected by rare clinical 
disorders, the discovery of common genetic variants that contribute to the wide normal variation in 
puberty timing, and other complex physiological traits, has accelerated only in the last 5-10 years since 
the advent of genome-wide association studies (GWAS). This approach allows the concurrent analysis of 
millions of single nucleotide polymorphisms (SNPs) across the genome in very large individual-based 
study designs to provide the statistical power that is necessary to robustly identify genomic regions of 
association.  
Four recent large-scale GWAS have been reported for puberty timing, adiposity and adult height (Table 
1). A GWAS for age at menarche identified 123 independent signals at 106 genomic loci 35.  The strongest 
individual signal, a SNP near to LIN28B, altered age at menarche by 0.11 years per allele, and in total the 
top 123 SNPs explained 2.7% of the population variance in puberty timing. Secondly, a GWAS for BMI in 
adults identified 97 genomic loci, of which 56 had not been previously linked to any measure of adiposity; 
taken together the top 97 SNPs explained around 2.7% of the variance in adult BMI36. Thirdly, a parallel 
project by the same investigators identified 49 genomic loci, of which 33 were novel, robustly associated 
with measures of central-to-peripheral distribution of body shape and adiposity; the effects were larger 
in women than in men likely reflecting the greater heritability in hip circumference in women. Together 
the top SNPs explained 2.4% of the variance in ‘waist-to-hip ratio adjusted for BMI’ in women compared 
to only 0.8% of the variance in this trait in men37. Finally, a remarkable 697 independent signals at 423 
loci were associated with adult height; together these top SNPs explained 16% of the variance in adult 
height and the investigators extrapolated that thousands of common variants across the genome account 
for ~50% of variance38. 
Notably, all of these recent GWAS relied on traits that were measured or self-reported by adults, 
reflecting the relative paucity of genetic data in children, and therefore the role of these genetic variants 
on detailed childhood phenotypes is mostly unclear. A recent GWAS for childhood timing of ‘Tanner 
puberty stages’ in 6,147 girls and 3,997 boys did not identify any new loci for puberty timing, but 
confirmed the relevance of the LIN28B locus39 and the same dataset supported the likely relevance of the 
vast majority those loci recently identified for age at menarche in women to puberty timing in general in 
both boys and girls35. The reported menarche GWAS loci were enriched in/near genes that underlie rare 
disorders of puberty, including common variants in/near LEPR, GNRH1, PCSK1, PCSK2, POU1F1, TENM2 
and TACR3, as described above, which indicates their likely generic relevance to pubertal timing and 
reproductive function. 
Genetic co-regulation of BMI and puberty timing 
The existence of genetic co-regulation of BMI and age at menarche had been suggested by twin studies40, 
and this prediction has been validated in those recent GWAS findings. The list of shared loci between 
these two traits includes the following 13 genomic regions in or near: FTO, SEC16B, TMEM18, NEGR1, 
TNNI3K, GNPDA2, BDNF, BCDIN3D, GPRC5B, GALNT10, MAP2K5, TRIM66 and LRP1B. At all of these loci, 
the BMI-increasing allele is also associated with earlier age at menarche, which is directionally 
concordant with the observed epidemiology association between BMI and age at menarche. In addition to 
these 13 ‘top signals’ identified as passing stringent statistical criteria for each trait, our analysis across 
all of the 97 recently reported BMI loci shows an overall linear correlation between the reported effects 
on BMI36 and those reported on age at menarche35 (R-square=0.26), indicative of a general mechanism 
linking these two traits (Figure 2). 
However, there are some exceptions to this pattern, which could indicate other specific mechanisms that 
act on BMI and puberty timing. Firstly, the BMI locus near MC4R has the fourth largest estimated effect 
size on BMI41 (and has similar effects on BMI in men and women42), but shows no association at all with 
age at menarche (P=0.1935) (Figure 2), which suggest that it regulates BMI through a mechanism 
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different to most other genetic factors. Intriguingly, at this locus the BMI-increasing SNP is also associated 
with later-puberty in boys (P=0.0009)39. Further genetic studies in boys might shed light on the highly 
variable reportedly effects of BMI on puberty timing in observational epidemiological studies43,44. 
Secondly, a locus for age at menarche is located close to the BMI locus at ETV5; however the genetic 
signals for these traits are not correlated, which may indicate heterogeneity in downstream biological 
mechanisms45. Lastly, our analysis of these reported findings and other publically available datasets 
indicates that loci that regulate both BMI and age at menarche are also enriched for associations with 
fasting insulin levels, which could indicate a specific mechanism that potentially links these two traits 
(Figure 3). 
In contrast to the reported BMI loci, the genetic loci reported for measures of central-to-peripheral 
distribution of body shape and adiposity show little relevance for age at menarche37. Only one locus for 
WHR-adjusted-for-BMI (at LEKR1) is also identified as a locus for age at menarche35. Notably, this LEKR1 
locus is also reported to regulate birth weight46 and the menarche age-raising allele was also associated 
with higher birth weight, which is directionally concordant with observed epidemiological observation47. 
Therefore, while earlier age at menarche might predispose to greater central adiposity through its effects 
on promoting weight gain and BMI48, GWAS findings do not yet support any distinct mechanisms linking 
these traits.   
Genetic co-regulation of height and puberty timing 
There is good evidence from observational studies in the general population that (as is seen in girls with 
the clinical disorder precocious puberty49) girls who develop puberty earlier than average are taller than 
other girls during childhood and adolescence but are shorter as adults due to earlier epiphyseal bone 
fusion50 (in contrast there appears no association with adult height in men51). This complex relationship 
between height and puberty timing in females is reflected in the genetic co-regulation of these traits. The 
GWAS findings for age at menarche include three loci that were also reported as GWAS loci for adult 
height, however there was directional inconsistency in these overlapping findings. The menarche age-
raising alleles at the LIN28B and SIX6 loci are also associated with taller adult height, which is 
directionally-concordant with the phenotypic association. Conversely, at the CENPW/NCOA7 locus, the 
menarche age-raising allele is also associated with shorter adult height. Our analysis across all 123 
signals identified for age at menarche shows distinct clusters of age at menarche alleles that are 
associated with either taller or shorter adult height (Figure 3). Clarification between such mechanisms, 
which promote both faster childhood growth and earlier puberty timing but have distinct effects on adult 
height potential, could have major clinical and public health benefits. 
Epigenetic regulation of puberty timing 
The recent GWAS for age at menarche in women identified loci at three imprinted gene regions, MKRN3-
MAGEL2, DLK1, and KCNK9, which showed parent-of-origin specific associations that were concordant 
with the established parent-of-origin specific mRNA expression patterns. Thus, at the exclusively 
paternally-expressed loci (MKRN3-MAGEL2 and DLK1) only the paternally-inherited alleles (but not the 
maternally-inherited alleles) showed associations with menarche timing, and vice versa for the 
exclusively maternally-expressed locus, KCNK9. The association pattern at the MKRN3-MAGEL2 locus is 
also concordant with the paternal-specific inheritance of rare pathological mutations in MKRN320. 
Notably, a recent parent-of-origin specific GWAS for BMI identified two signals, including one near to 
KCNK9 52. Intriguingly, both paternally- and maternally-inherited alleles at KCNK9 are associated with 
BMI, but in opposite directions, and this SNP (rs2471083) is completely unrelated to the SNP identified 
for age at menarche (rs1469039; linkage disequilibrium r2= 0.001). Therefore, there may be distinct 
biological mechanisms regulated by this same imprinted region. 
More widely, there was enrichment of the 106 menarche-associated regions in known imprinted gene 
regions35.  The importance of imprinting on pathways relating to energy balance in animal models53 
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suggest that there may be further important motifs that also affect reproduction in humans. These 
findings indicate that the expression and phenotypic manifestation of some genetic factors that influence 
puberty timing are tightly regulated by stable epigenetic marks that reflect parental origin. 
In addition to gene imprinting, the recent GWAS findings strongly indicate the potential involvement of 
other epigenetic mechanisms in puberty timing. These include JmjC-domain-containing demethylases 
that catalyse gene activating epigenetic changes specifically at lysine 9 histone H3 marks35. Furthermore, 
a menarche-associated locus was identified at CBX7, which encodes a component of the Polycomb group 
of transcriptional silencers54. These GWAS findings support the likely relevance in humans of the 
reported close epigenetic regulation of reproductive timing in animal models. Pubertal onset in female 
rats is reportedly triggered by DNA methylation and decreased hypothalamic expression of two key 
Polycomb group genes, Eed and Cbx7, which in turn leads to enrichment of activating lysine modifications 
on histone H3 and activation of expression of Kiss154. Studies in rhesus monkeys suggest that methylation 
and histone modification of the GnRH gene itself affect expression55. Beyond the completion of puberty 
and attainment of sexual maturity, epigenetic mechanisms may also contribute to the regulation of 
reproductive function, with epigenetic fluctuations observed across the female ovulation cycle56. 
Other mechanisms inferred by GWAS 
In addition to those menarche GWAS loci identified in/near genes that underlie rare disorders of puberty, 
other menarche loci point to potential new candidate genes or biological pathways for such disorders. A 
menarche locus on chromosome 5 lies near PCSK1, in which rare mutations cause severe early onset-
obesity and delayed/absent puberty was described in the one reported adult case57. The further 
menarche locus on chromosome 20 near PCSK2 strongly points to a common role of the encoded type 1 
and 2 prohormone convertases in the regulation of pubertal timing and reproductive function. Other 
menarche loci indicate candidate genes for GnRH neuron migration and pituitary development not yet 
linked to Kallmann syndrome and other hypothalamic/pituitary disorders. rs9647570 on chromosome 5 
lies within TENM2, which encodes a transmembrane protein expressed in developing brain and is 
induced by the product of the Kallmann syndrome gene FGF858. rs2479724 on chromosome 6 lies near 
FRS3, which encodes Fibroblast growth factor receptor substrate 3 and is involved in the signalling of the 
product of the Kallmann syndrome gene FGFR159. rs7103411 and rs1129700 are menarche signals 
strongly associated with expression levels of LGR4 and TBX6, respectively, which are both genes that 
encode enhancers for the pituitary development factor SOX2. We anticipate that further overlap with 
GWAS findings will be uncovered, particularly as studies of rare disorders incorporate exome-wide and 
genome-wide sequencing approaches. 
GWAS menarche loci were highly enriched in/near genes that encode nuclear hormone receptors, co-
activators or co-repressors, including those receptors involved in retinoic acid (RA) signalling. The 
cluster of retinoid receptors comprises the RA receptors (RARA, RARB and RARG), the retinoic X 
receptors (RXRA, RXRB and RXRG), and also the RAR-related orphan receptors (RORA, RORB, and RORC). 
They bind to RA response elements, activate gene transcription and have diverse functions across 
embryonic development (including GnRH neuron migration60), cell differentiation and homeostasis 
(including GnRH expression and secretion61). 
In addition to the substantial role of genetic determinants obesity susceptibility on pubertal timing, our 
findings indicate other mechanisms that could explain the epidemiological associations between early 
menarche and higher risks of adult disease, which are partially independent of BMI. The first studies for 
age at menarche identified variants intronic in LIN28B62–64, which encodes a potent and specific regulator 
of let-7 microRNA processing. Experimental overexpression of its homologue Lin28a promotes growth, 
delays pubertal onset and maturation and enhances insulin sensitivity, while fetal (but not neonatal or 
adult) deficiency of Lin28a and Lin28b impairs results in postnatal growth defects, insulin resistance and 
glucose intolerance65. Other possible mechanisms linking puberty timing to adult disease include actions 
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of GABAB receptor signalling on pancreatic beta cell function66, mitochondrial sirtuin 3 on cell responses 
to oxidative stress67, and DLK1/preadipocyte factor 1 on peripheral lipid oxidation and lipid storage68. 
Conclusions  
Genetic studies have underpinned our understanding of biological mechanisms that regulate puberty 
timing. Both monogenic studies of patients with rare disorders and polygenic studies of large population-
based samples support the key role of embryonic development and signalling pathways of the 
hypothalamic-pituitary axis, as well as important links between energy homeostasis, growth and 
development, which re-enforce the critical connection between energy balance and reproduction. While 
further evidence is needed to identify and confirm the causal genes at GWAS loci, pathway-based analyses 
provide strong evidence for mechanisms such as retinoid signalling and lysine-specific demethylases.  
Finally, the timing of childhood growth and development has been much debated as a trait with putative 
selection advantages. In adverse settings characterised by extremely high child and early adult mortality, 
early puberty and onset of reproductive maturity may increase fecundity despite the side effect of short 
adult height69. Conversely, in a recent analysis genetic variants associated with later age at menarche 
show evidence of positive selection in both European and African populations70. The enrichment of 
menarche-associated SNPs in imprinted gene regions further supports puberty timing as a selective trait 
and indicates parental conflict in this evolutionary perspective. Genomic imprinting results in monoallelic 
expression exclusively from the maternal or paternal copy. It affects only around 100 mammalian genes 
and supposedly evolved to control the dosage of developmentally important genes, such as those that 
regulate placentation, embryonic growth, infant feeding or parenting71. It has been hypothesized that 
paternal fitness is enhanced by maximising resource allocation to his offspring; while maternal fitness is 
enhanced by reserving resources for her subsequent children72,73.  In addition to such reflective insights, 
the increasing evidence implicating epigenetic mechanisms in puberty timing and reproductive function 
may inform future understanding of early life programming and therapeutic strategies.   
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Table 1: Recent genome-wide association studies (GWAS) for puberty timing and anthropometric 
outcomes. 
Reference Phenotype Study size Number of  
genomic loci 
(novel loci) 
Number of 
independent 
signals 
Variance 
explained by the 
top signals 
Perry et al (2014) Age at Menarche 
182,427 
(women only) 
106 (65) 123 2.7% 
Locke et al (2015) Adult BMI 339,224 97 (56) 103 2.7% 
Shungin et al 
(2015) 
Adult Waist-to-hip 
ratio  
(adjusted for BMI) 
224,459 49 (33) 65 
2.4% (women) 
0.8% (men) 
Wood et al (2014) Adult Height 253,288 423 (243) 697 16% 
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Figure 1. Schematic diagram of the biology of puberty initiation, knowledge from rare and mono-
genetic studies is bounded in red, the suggested mechanisms of common variants are bounded in 
green. 
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Figure 2 . Plot of the 97 common variants identified by genome-wide association studies for BMI, 
indicating their per-allele effect sizes on adult BMI (with 95% confidence intervals) compared to their 
effect sizes on age at menarche. The R2 value indicates the strength of correlation between effect 
sizes. In general, BMI-increasing alleles also confer earlier menarche. The MC4R-region variant 
(highlighted in red) is a notable exception.  
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Figure 3. Heatmap indicating the effects of 123 common variants identified for age at menarche on a 
number of metabolic-related phenotypes (data derived from publically-available datasets41,46,74–78). 
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Green bars indicate menarche age-decreasing variants that are also associated with higher values of 
other phenotypes; blue indicates menarche age-decreasing variants also associated with lower 
values of other phenotypes. 
 
 
  
12 
 
1. Parent, A. S. et al. The timing of normal puberty and the age limits of sexual precocity: variations 
around the world, secular trends, and changes after migration. Endocr Rev 24, 668–693 (2003). 
2. Elks, C. E. et al. Age at Menarche and Type 2 Diabetes Risk: The EPIC-InterAct study. Diabetes Care 
36, 3526–34 (2013). 
3. Lakshman, R. et al. Early age at menarche associated with cardiovascular disease and mortality. J. 
Clin. Endocrinol. Metab. 94, 4953–60 (2009). 
4. Morris, D. H., Jones, M. E., Schoemaker, M. J., Ashworth, A. & Swerdlow, A. J. Secular trends in age at 
menarche in women in the UK born 1908-93: results from the Breakthrough Generations Study. 
Paediatr. Perinat. Epidemiol. 25, 394–400 (2011). 
5. Hosokawa, M., Imazeki, S., Mizunuma, H., Kubota, T. & Hayashi, K. Secular trends in age at 
menarche and time to establish regular menstrual cycling in Japanese women born between 1930 
and 1985. BMC Womens. Health 12, 19 (2012). 
6. Cabanes, A. et al. Decline in age at menarche among Spanish women born from 1925 to 1962. BMC 
Public Health 9, 449 (2009). 
7. Euling, S. Y. et al. Examination of US puberty-timing data from 1940 to 1994 for secular trends: 
panel findings. Pediatrics 121 Suppl , S172–91 (2008). 
8. Adanu, R. M. K. et al. Secular trends in menarcheal age among Ghanaian women in Accra. J. Obstet. 
Gynaecol. 26, 550–554 (2006). 
9. Silva, H. P. & Padez, C. Secular trends in age at menarche among Caboclo populations from Pará, 
Amazonia, Brazil: 1930-1980. Am. J. Hum. Biol. 18, 83–92 (2006). 
10. Sørensen, K., Aksglaede, L., Petersen, J. H. & Juul, A. Recent changes in pubertal timing in healthy 
Danish boys: associations with body mass index. J. Clin. Endocrinol. Metab. 95, 263–70 (2010). 
11. Kaplowitz, P. Pubertal development in girls: secular trends. Curr. Opin. Obstet. Gynecol. 18, 487–
491 (2006). 
12. Herbison, A. E. Genetics of puberty. Horm. Res. 68 Suppl 5, 75–9 (2007). 
13. Valdes-Socin, H. et al. Reproduction, smell, and neurodevelopmental disorders: genetic defects in 
different hypogonadotropic hypogonadal syndromes. Front. Endocrinol. (Lausanne). 5, 109 
(2014). 
14. Layman, L. C. et al. Delayed puberty and hypogonadism caused by mutations in the follicle-
stimulating hormone beta-subunit gene. N. Engl. J. Med. 337, 607–611 (1997). 
15. Aittomäki, K. et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary 
hypergonadotropic ovarian failure. Cell 82, 959–968 (1995). 
16. Tüttelmann, F. et al. Combined effects of the variants FSHB -211G>T and FSHR 2039A>G on male 
reproductive parameters. J. Clin. Endocrinol. Metab. 97, 3639–47 (2012). 
17. Weiss, J. et al. Hypogonadism caused by a single amino acid substitution in the beta subunit of 
luteinizing hormone. N. Engl. J. Med. 326, 179–83 (1992). 
18. Teles, M. G. et al. A GPR54-activating mutation in a patient with central precocious puberty. N. 
Engl. J. Med. 358, 709–15 (2008). 
13 
 
19. Silveira, L. G. et al. Mutations of the KISS1 gene in disorders of puberty. J. Clin. Endocrinol. Metab. 
95, 2276–80 (2010). 
20. Abreu, A. P. et al. Central precocious puberty caused by mutations in the imprinted gene MKRN3. 
N. Engl. J. Med. 368, 2467–75 (2013). 
21. Schreiner, F., Gohlke, B., Hamm, M., Korsch, E. & Woelfle, J. MKRN3 mutations in familial central 
precocious puberty. Horm. Res. pædiatrics 82, 122–6 (2014). 
22. Macedo, D. B. et al. Central precocious puberty that appears to be sporadic caused by paternally 
inherited mutations in the imprinted gene makorin ring finger 3. J. Clin. Endocrinol. Metab. 99, 
E1097–103 (2014). 
23. Bernard, G. et al. Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III 
cause a recessive hypomyelinating leukodystrophy. Am. J. Hum. Genet. 89, 415–23 (2011). 
24. Margolin, D. H. et al. Ataxia, dementia, and hypogonadotropism caused by disordered 
ubiquitination. N. Engl. J. Med. 368, 1992–2003 (2013). 
25. Shi, Y. et al. Identification of CHIP as a novel causative gene for autosomal recessive cerebellar 
ataxia. PLoS One 8, e81884 (2013). 
26. Shi, C.-H. et al. Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box 
protein CHIP. Hum. Mol. Genet. 23, 1013–24 (2014). 
27. Montague, C. T. et al. Congenital leptin deficiency is associated with severe early-onset obesity in 
humans. Nature 387, 903–908 (1997). 
28. Chehab, F. F. Early Onset of Reproductive Function in Normal Female Mice Treated with Leptin. 
Science (80-. ). 275, 88–90 (1997). 
29. Strobel, A., Issad, T., Camoin, L., Ozata, M. & Strosberg, A. D. A leptin missense mutation associated 
with hypogonadism and morbid obesity. Nat. Genet. 18, 213–5 (1998). 
30. Clement, K. A mutation in the human leptin receptor gene causes obesity and pituitary 
dysfunction. Nature 392, 398–401 (1998). 
31. Farooqi, I. S. et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and 
neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 110, 
1093–103 (2002). 
32. Cheung, C. C. et al. Leptin is a metabolic gate for the onset of puberty in the female rat. 
Endocrinology 138, 855–8 (1997). 
33. Farooqi, I. S. et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin 
receptor. N. Engl. J. Med. 356, 237–247 (2007). 
34. Weedon, M. N. et al. An in-frame deletion at the polymerase active site of POLD1 causes a 
multisystem disorder with lipodystrophy. Nat. Genet. 45, 947–50 (2013). 
35. Perry, J. R. B. et al. Parent-of-origin-specific allelic associations among 106 genomic loci for age at 
menarche. Nature 514, 92–97 (2014). 
36. Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 
518, 197–206 (2015). 
14 
 
37. Shungin, D. et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 
518, 187–196 (2015). 
38. Wood, A. R. et al. Defining the role of common variation in the genomic and biological architecture 
of adult human height. Nat. Genet. 46, 1173–1186 (2014). 
39. Cousminer, D. L. et al. Genome-wide association study of sexual maturation in males and females 
highlights a role for body mass and menarche loci in male puberty. Hum. Mol. Genet. 23, 4452–64 
(2014). 
40. Kaprio, J. et al. Common genetic influences on BMI and age at menarche. Hum Biol 67, 739–753 
(1995). 
41. Speliotes, E. K. et al. Association analyses of 249,796 individuals reveal 18 new loci associated 
with body mass index. Nat. Genet. 42, 937–48 (2010). 
42. Randall, J. C. et al. Sex-stratified Genome-wide Association Studies Including 270,000 Individuals 
Show Sexual Dimorphism in Genetic Loci for Anthropometric Traits. PLoS Genet. 9, e1003500 
(2013). 
43. Juul, A., Magnusdottir, S., Scheike, T., Prytz, S. & Skakkebaek, N. E. Age at voice break in Danish 
boys: effects of pre-pubertal body mass index and secular trend. Int. J. Androl. 30, 537–42 (2007). 
44. Lee, J. M. et al. Body mass index and timing of pubertal initiation in boys. Arch. Pediatr. Adolesc. 
Med. 164, 139–44 (2010). 
45. Elks, C. E. et al. Thirty new loci for age at menarche identified by a meta-analysis of genome-wide 
association studies. Nat Genet 42, 1077–1085 (2010). 
46. Horikoshi, M. et al. New loci associated with birth weight identify genetic links between 
intrauterine growth and adult height and metabolism. Nat. Genet. 45, 76–82 (2013). 
47. D’Aloisio, A. A., DeRoo, L. A., Baird, D. D., Weinberg, C. R. & Sandler, D. P. Prenatal and infant 
exposures and age at menarche. Epidemiology 24, 277–84 (2013). 
48. Mueller, N. T. et al. Earlier menarche is associated with fatty liver and abdominal ectopic fat in 
midlife, independent of young adult BMI: The CARDIA study. Obesity (Silver Spring). 23, 468–74 
(2015). 
49. Willemsen, R. H., Elleri, D., Williams, R. M., Ong, K. K. & Dunger, D. B. Pros and cons of GnRHa 
treatment for early puberty in girls. Nat. Rev. Endocrinol. 10, 352–63 (2014). 
50. Onland-Moret, N. C. et al. Age at menarche in relation to adult height: the EPIC study. Am. J. 
Epidemiol. 162, 623–32 (2005). 
51. Ong, K. K. et al. Timing of voice breaking in males associated with growth and weight gain across 
the life course. J. Clin. Endocrinol. Metab. 97, 2844–52 (2012). 
52. Hoggart, C. J. et al. Novel Approach Identifies SNPs in SLC2A10 and KCNK9 with Evidence for 
Parent-of-Origin Effect on Body Mass Index. PLoS Genet. 10, e1004508 (2014). 
53. Peters, J. The role of genomic imprinting in biology and disease: an expanding view. Nat. Rev. 
Genet. 15, 517–530 (2014). 
54. Lomniczi, A. et al. Epigenetic control of female puberty. Nat. Neurosci. 16, 281–9 (2013). 
15 
 
55. Kurian, J. R. & Terasawa, E. Epigenetic control of gonadotropin releasing hormone neurons. Front. 
Endocrinol. (Lausanne). 4, 61 (2013). 
56. Kanherkar, R. R., Bhatia-Dey, N. & Csoka, A. B. Epigenetics across the human lifespan. Front. cell 
Dev. Biol. 2, 49 (2014). 
57. Jackson, R. S. et al. Obesity and impaired prohormone processing associated with mutations in the 
human prohormone convertase 1 gene. Nat. Genet. 16, 303–6 (1997). 
58. Tucker, R. P. et al. Teneurin-2 is expressed in tissues that regulate limb and somite pattern 
formation and is induced in vitro and in situ by FGF8. Dev. Dyn. 220, 27–39 (2001). 
59. Hoch, R. V & Soriano, P. Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 
during mouse development. Development 133, 663–73 (2006). 
60. Nagl, F. et al. Retinoic acid-induced nNOS expression depends on a novel PI3K/Akt/DAX1 pathway 
in human TGW-nu-I neuroblastoma cells. Am. J. Physiol. Cell Physiol. 297, C1146–56 (2009). 
61. Cho, S., Cho, H., Geum, D. & Kim, K. Retinoic acid regulates gonadotropin-releasing hormone 
(GnRH) release and gene expression in the rat hypothalamic fragments and GT1-1 neuronal cells 
in vitro. Brain Res. Mol. Brain Res. 54, 74–84 (1998). 
62. Perry, J. R. B. et al. Meta-analysis of genome-wide association data identifies two loci influencing 
age at menarche. Nat. Genet. 41, 648–50 (2009). 
63. Ong, K. K. et al. Genetic variation in LIN28B is associated with the timing of puberty. Nat. Genet. 41, 
729–33 (2009). 
64. He, C. et al. A large-scale candidate gene association study of age at menarche and age at natural 
menopause. Hum. Genet. 128, 515–27 (2010). 
65. Shinoda, G. et al. Fetal deficiency of lin28 programs life-long aberrations in growth and glucose 
metabolism. Stem Cells 31, 1563–73 (2013). 
66. Tian, J., Dang, H., Nguyen, A. V., Chen, Z. & Kaufman, D. L. Combined therapy with GABA and 
proinsulin/alum acts synergistically to restore long-term normoglycemia by modulating T-cell 
autoimmunity and promoting β-cell replication in newly diabetic NOD mice. Diabetes 63, 3128–34 
(2014). 
67. Kumar, S. & Lombard, D. B. Mitochondrial Sirtuins and Their Relationships with Metabolic Disease 
and Cancer. Antioxid. Redox Signal. (2015). doi:10.1089/ars.2014.6213 
68. Charalambous, M. et al. DLK1/PREF1 regulates nutrient metabolism and protects from steatosis. 
Proc. Natl. Acad. Sci. U. S. A. 111, 16088–93 (2014). 
69. Migliano, A. B., Vinicius, L. & Lahr, M. M. Life history trade-offs explain the evolution of human 
pygmies. Proc. Natl. Acad. Sci. U. S. A. 104, 20216–9 (2007). 
70. Fagny, M. et al. Exploring the occurrence of classic selective sweeps in humans using whole-
genome sequencing data sets. Mol. Biol. Evol. 31, 1850–68 (2014). 
71. Bartolomei, M. S. & Ferguson-Smith, A. C. Mammalian genomic imprinting. Cold Spring Harb. 
Perspect. Biol. 3, (2011). 
72. Wilkins, J. F. & Haig, D. What good is genomic imprinting: the function of parent-specific gene 
expression. Nat Rev Genet 4, 359–368 (2003). 
16 
 
73. Crespi, B. The evolutionary biology of child health. Proc. Biol. Sci. 278, 1441–9 (2011). 
74. Lango Allen, H. et al. Hundreds of variants clustered in genomic loci and biological pathways affect 
human height. Nature 467, 832–8 (2010). 
75. Scott, R. A. et al. Large-scale association analyses identify new loci influencing glycemic traits and 
provide insight into the underlying biological pathways. Nat. Genet. 44, 991–1005 (2012). 
76. Manning, A. K. et al. A genome-wide approach accounting for body mass index identifies genetic 
variants influencing fasting glycemic traits and insulin resistance. Nat Genet 44, 659–669 (2012). 
77. Morris, A. P. et al. Large-scale association analysis provides insights into the genetic architecture 
and pathophysiology of type 2 diabetes. Nat. Genet. 44, 981–990 (2012). 
78. Heid, I. M. et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals 
sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 42, 949–60 (2010).  
 
